Gliclazide: all 23 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM PatientsRecruitingNCT06217887Not applicable
- Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid MetabolisersCompletedNCT04198948Phase 1Results posted
- Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy ParticipantsCompletedNCT03467945Phase 1Results posted
- A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)CompletedNCT01709305Phase 4Results posted
- Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug TreatmentCompletedNCT01022762Phase 4Results posted
- Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 DiabetesCompletedNCT00367055Phase 4Results posted
- Comparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With GlucotoxicityCompletedNCT06613750Phase 4
- Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical TrialCompletedNCT06085703Not applicable
- Study of Sulphonylurea Synergy With IncretinsCompletedNCT03705195Not applicable
- Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetESStatus unknownNCT03433248Phase 4
- Antidiabetic Effects on Intrahepatic FatCompletedNCT03068065Phase 4
- Bioequivalence Study of Gliclazide 120 mg Modified Release TabletsWithdrawnNCT02980757Phase 1
- HbA1c Variability in Type II DiabetesActive, not recruitingNCT02879409Not applicable
- Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy VolunteersCompletedNCT02777671Phase 1
- Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet FormulationsCompletedNCT02643329Phase 1
- Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to GliclazideCompletedNCT02610088Phase 4
- Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over StudyCompletedNCT02201602Phase 4
- Safety Evaluation of Adverse Reactions in DiabetesCompletedNCT02092597Phase 4
- MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 DiabetesCompletedNCT01847144Phase 4
- The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 DiabetesCompletedNCT01420692Not applicable
- Variation in Sulphonylurea Response in Type 2 DiabetesTerminatedNCT00738088Phase 4
- Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With AnginaWithdrawnNCT00225342Phase 4
- Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic PatientsCompletedNCT00147836Not applicable